reduced
estriol
excretion
patients
breast
cancer
prior
endocrine
therapy
urinary
quotient
estriol/estrone
estradiol17beq
measured
chemically
women
without
breast
cancer
dex
ratio
noncarcinogenic
impeded
es
trogens
mammary
carcinogenic
estrogens
controls
median
eq
menopause
patients
sub
normal
breast
cancer
patients
without
endo
crine
treatment
recent
surgery
median
eq
respectively
pa
tients
subnormal
major
surgery
hormo
nal
therapy
patients
subnor
mal
remissions
observed
unless
eq
rose
toward
normal
matching
controls
patients
pairs
age
ovarian
status
wilcoxon
test
indicated
decreased
eq
ex
creted
untreated
cancer
significant
confidence
level
marked
increase
eq
induced
castration
androgen
estrogen
corticosteroid
therapy
suggests
normaliza
tion
a
precancerous
metabolic
imbalance
tween
impeded
active
estrogens
derived
ovarian
adrenocortical
sources
contributed
arrested
growth
estradioldependent
metastases
